Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth Hormone in Middle-Aged Men With Metabolic Syndrome
NCT00307411Phase 4Unknown
- Sponsor
- The Chinese University of Hong Kong
- Start
- Aug 2006
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in metabolic syndrome comparing Growth hormone with Placebo (2 arms). Primary endpoint: Change in percentage of body fat from baseline at 12 months. Status: unknown.
02
Drugs
somatropin
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT00307411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00307411.